Aspergillus infection in lung transplant recipients with cystic fibrosis: Risk factors and outcomes comparison to other types of transplant recipients

Chest

Volumn 123, Issue 3, 2003, Pages 800-808

  Helmi, Mohamed ^a   Love, Robert B ^a   Welter, Debbie ^a   Cornwell, Richard D ^a   Meyer, Keith C ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

Aspergillus; Lung transplantation; Respiratory tract infection

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT;

ADULT; ANASTOMOSIS DEHISCENCE; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOMEGALOVIRUS INFECTION; DEBRIDEMENT; DONOR; FEMALE; FUNGUS ISOLATION; HEART LUNG TRANSPLANTATION; HUMAN; INCIDENCE; LUNG INFARCTION; LUNG TRANSPLANTATION; MALE; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RECIPIENT; RETROSPECTIVE STUDY; RISK FACTOR; SECRETION; SURVIVAL TIME; TISSUE NECROSIS; TRACHEOBRONCHIAL TREE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0037335939     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.3.800     Document Type: Article

References (29)

1. Milla CE, Wielinski CL, Regelmann WE. Clinical significance of the recovery of Aspergillus species from the respiratory secretions of cystic fibrosis patients. Pediatr Pulmonol 1996; 21:6-10
2. Flume PA, Egan TM, Paradowski LJ, et al. Infectious complications of lung transplantation: impact of cystic fibrosis. Am J Respir Crit Care Med 1994; 149:1601-1607
3. Geller DE, Kaplowitz H, Light MJ, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Chest 1999; 116:639-646
4. Mastella G, Rainisio M, Harms HK, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis: a European epidemiological study. Eur Respir J 2000; 16:464-471
5. Maguire CP, Hayes JP, Hayes M, et al. Three cases of pulmonary aspergilloma in adult patients with cystic fibrosis. Thorax 1995; 50:805-806
6. Kramer MR, Marshall SE, Starnes VA, et al. Infectious complications in heart-lung transplantation: analysis of 200 episodes. Arch Intern Med 1993; 153:2010-2016
7. Westney GE, Kesten S, de Hoyos A, et al. Aspergillus infection in single and double lung transplant recipients. Transplant 1996; 61:915-919
8. Mehrad B, Paciocco G, Martinez FJ, et al. Spectrum of aspergillus infection in lung transplant recipients: case series and review of the literature. Chest 2001; 119:169-175
9. Cahill BC, Hibbs JR, Savik K, et al. Aspergillus airway colonization and invasive disease after lung transplantation. Chest 1997; 112:1160-1164
10. Nunley DR, Ohori NP, Grgurich WF, et al. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest 1998; 114:1321-1329
11. Nathan SD, Shorr F, Schmidt ME, et al. Aspergillus and endobronchial abnormalities in lung transplant recipients. Chest 2000; 118:403-407
12. Kanj SS, Tapson V, David D, et al. Infections in patients with cystic fibrosis following lung transplantation. Chest 1997; 112:924-930
13. Husni RN, Gordon SM, Longworth DL, et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis 1998; 26:753-755
14. Kramer MR, Denning DW, Marshall SE, et al. Ulcerative tracheobronchitis after lung transplantation: a new form of invasive aspergillosis. Am Rev Respir Dis 1991; 144:552-556
15. Guillemain R, Lavarde V, Amrein C, et al. Invasive aspergillosis after transplantation. Transplant Proc 1995; 27:1307-1309
16. Yeldandi V, Laghi F, McCabe MA, et al. Aspergillus and lung transplantation. J Heart Lung Transplant 1995; 14:883-890
17. Bertocchi M, Thevenet F, Bastien O, et al. Fungal infections in lung transplant recipients. Transplant Proc 1995; 27:1695
18. Patterson TF, Peters J, Levine SM, et al. Systemic availability of itraconazole in lung transplantation. Antimicrob Agents Chemother 1996; 40:2217-2220
19. Reichenspurner H, Gamberg P, Nitschke M, et al. Significant reduction in the number of fungal infections after lung, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis. Transplant Proc 1997; 29:627-628
20. Calvo V, Borro JM, Morales P, et al. Angifungal prophylaxis during the early postoperative period of lung transplantation. Chest 1999; 115:1301-1304
21. Birsan T, Taghavi S, Klepetko W. Treatment of aspergillus-related ulcerative tracheobronchitis in lung transplant recipients. J Heart Lung Transplant 1998; 17:437-438
22. 1-antiprotease defenses following human lung transplantation. Am J Respir Crit Care Med 2001; 164:97-102
23. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996; 15:1-15
24. Kessler RR, Massard G, Warter A, et al. Bronchial-pulmonary artery fistula after unilateral lung transplantation: a case report. J Heart Lung Transplant 1997; 16:674-677
25. Paradowski LJ. Saprophytic fungal infections and lung transplantation: revisited. J Heart Lung Transplant 1997; 16:524-531
26. Hamacher J, Spiliopoulos A, Kurt AM, et al. Pre-emptive therapy with azoles in lung transplant patients: Geneva Lung Transplantation Group. Eur Respir J 1999; 13:180-186
27. Brenier-Pinchart MP, Lebeau B, Devouassoux G, et al. Aspergillus and lung transplant recipients: a mycologic and molecular epidemiologic study. J Heart Lung Transplant 1998; 17:972-979
28. Drent M, van Rens MTM, Wagenaar SS, et al. Invasive aspergillosis after bilateral lung transplantation in cystic fibrosis. Respir Med 1995; 89:449-451
29. Henke JA, Golden JA, Yelin EH, et al. Persistent increase of BAL neutrophils as a predictor of mortality following lung transplant. Chest 1999; 115:403-409